Cancer Cachexia

Actimed secures extra £4.75M funding towards 'first globally approved product' treating cancer cachexia
Outsourcing Pharma
Tue, 08/22/23 - 10:13 am
Actimed Therapeutics
funding
Cancer Cachexia
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Zolmax
Sun, 10/21/12 - 11:10 am
Ohr Pharmaceutical
macular degeneration
Squalamine Eye Drops
OHR/AVR 118
Cancer Cachexia